top of page
1994: FDA VRBPAC meeting. The stated purpose of the meeting was to determine whether
Read the transcript for yourself. At the end, they announced that after a brief recess during which the room would be swept for listening devices, there would be a closed-door session with the representatives of SmithKline, maker of LYMErix.
​
bottom of page